Annemarie Bianka Weise

Annemarie Bianka Weise

Auto-generated profile, based on publicly available information

Annemarie Bianka Weise

Junior Research Group (Bio-)medical Data Science, Faculty of Medicine, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2024 in JMIR Research Protocols
Verified
Journal Article
Open access
IMIryna Manuilova
Iryna Manuilova
JBJan Bossenz
Jan Bossenz
AWAnnemarie Bianka Weise
Annemarie Bianka Weise
DBDominik Boehm
Dominik Boehm
CSCosima Strantz
Cosima Strantz
JCJan Christoph
Jan Christoph
Background: Understanding the similarities of patients with cancer is essential to advancing personalized medicine, improving patient outcomes, and developing more effective and individualized treatments. It enables researchers to discover important patterns, biomarkers, and treatment strategies that can have a significant impact on cancer research and oncology. In addition, the identification of previously successfully treated patients supports oncologists in making treatment decisions for a new patient who is clinically or molecularly similar to the previous patient. Objective: The planned review aims to systematically summarize, map, and describe existing evidence to understand how patient similarity is defined and used in cancer research and clinical care. Methods: To systematically identify relevant studies and to ensure reproducibility and transparency of the review process, a comprehensive literature search will be conducted in several bibliographic databases, including Web of Science, PubMed, LIVIVIVO, and MEDLINE, covering the period from 1998 to February 2024. After the initial duplicate deletion phase, a study selection phase will be applied using Rayyan, which consists of 3 distinct steps: title and abstract screening, disagreement resolution, and full-text screening. To ensure the integrity and quality of the selection process, each of these steps is preceded by a pilot testing phase. This methodological process will culminate in the presentation of the final research results in a structured form according to the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) flowchart. The protocol has been registered in the Journal of Medical Internet Research. Results: This protocol outlines the methodologies used in conducting the scoping review. A search of the specified electronic databases and after removing duplicates resulted in 1183 unique records. As of March 2024, the review process has moved to the full-text evaluation phase. At this stage, data extraction will be conducted using a pretested chart template. Conclusions: The scoping review protocol, centered on these main concepts, aims to systematically map the available evidence on patient similarity among patients with cancer. By defining the types of data sources, approaches, and methods used in the field, and aligning these with the research questions, the review will provide a foundation for future research and clinical application in personalized cancer care. This protocol will guide the literature search, data extraction, and synthesis of findings to achieve the review’s objectives. International Registered Report Identifier (IRRID): DERR1-10.2196/58705

15 May 2025
Verified
Book Chapter
Open access
PDF file
JBJan Bossenz
Jan Bossenz
IMIryna Manuilova
Iryna Manuilova
AWAnnemarie Bianka Weise
Annemarie Bianka Weise
SSSusann Schulze
Susann Schulze
SHSonja Hiemer
Sonja Hiemer
JCJan Christoph
Jan Christoph
Background: Patient similarity analysis is pivotal in cancer research and clinical oncology, aiding in identifying patterns among patients with similar clinical and molecular profiles to guide therapeutic decisions, particularly in Molecular Tumor Boards (MTB), where therapy decisions are frequently informed by the treatment experiences of previously treated similar patients. However, the lack of standardized tools for automation and visualization limits efficiency here, especially in individualized MTB decisions. Objective: This study aims to develop a graphical user interface that aligns with clinician preferences to enhance patient similarity assessments and support decision-making in MTBs. Methods: Visualization concepts were developed through iterative design and evaluation cycles involving clinical experts. Mock-ups were created to represent various approaches for displaying patient similarities, focusing on molecular data relevant to MTB decisions. Results: Various designs were developed for visualizing patient similarity in cBioPortal. These include tabular views, network representations, and radar plots. Conclusions: These visualizations offer promise in enhancing decision-making in MTBs by making patient similarity assessments more accessible. Future development will focus on additional functionalities and better integration into clinical workflows.

18 August 2025 in Journal of Medical Internet Research
Verified
Journal Article
Open access
IMIryna Manuilova
Iryna Manuilova
JBJan Bossenz
Jan Bossenz
AWAnnemarie Bianka Weise
Annemarie Bianka Weise
DBDominik Boehm
Dominik Boehm
MDMarvin Döbel
Marvin Döbel
JCJan Christoph
Jan Christoph
Background: Patient similarity is a fundamental concept in precision oncology, offering a pathway to personalized medicine by identifying patterns and shared characteristics among patients. This concept enables stratification into clinically meaningful subgroups, prediction of treatment responses, and the tailoring of therapeutic interventions to individual needs. Despite its transformative potential, the definition, measurement, and clinical application of patient similarity remain inconsistently established, creating challenges in its integration into cancer research and clinical practice. Objective: This study aimed to synthesize evidence on the multidimensional concept of patient similarity in cancer research by analyzing its application across different points of possible data types, methodological frameworks, biological contexts, and commonly studied cancer types. Methods: This scoping review followed the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews) framework and the Joanna Briggs Institute guidelines. A systematic search was conducted across PubMed, MEDLINE, LIVIVO, and Web of Science (covering the period from 1998 to February 2024) and was supplemented by snowball sampling and manual searches. Duplicate records were removed, and study selection was carried out in 3 phases: title and abstract screening, disagreement resolution, and full-text screening. Each step was independently performed by 2 reviewers in Rayyan, with conflicts resolved by a third reviewer. Data extraction was performed using a predefined template to capture methodological approaches, data types, cancer types, and research objectives related to similarity in patients with cancer. Results: This scoping review synthesized evidence from 137 studies, emphasizing the multidimensional concept of patient similarity in cancer research, which integrates diverse data types, methodological frameworks, research objectives, and cancer types. Transcriptomic data (92/137, 67.1%) and clinical data (65/137, 47.4%) were the most frequently used, often combined to enhance the comprehensiveness of similarity analyses. Machine learning (76/137, 55.5%) and network-based approaches (72/137, 52.5%) were prominent methods, reflecting their capacity to handle complex, high-dimensional data and uncover intricate relationships. Cancer subtype identification (70/137, 51.1%) and biomarker discovery (41/137, 29.9%) were the primary research objectives, underscoring the centrality of patient similarity in precision oncology. Breast, lung, and brain cancers were the most frequently studied, benefiting from established research frameworks and abundant datasets. Conversely, rare cancers were underrepresented, highlighting a critical gap in the generalizability of current methodologies. Conclusions: This comprehensive scoping review examines the concept of patient similarity in cancer research and highlights the critical role of a multilayered perspective in capturing its complexity and identification to enhance understanding and application in precision oncology.

31 January 2025 in JMIR Preprints
Verified
Preprint
Open access
IMIryna Manuilova
Iryna Manuilova
JBJan Bossenz
Jan Bossenz
AWAnnemarie Bianka Weise
Annemarie Bianka Weise
DBDominik Boehm
Dominik Boehm
MDMarvin Döbel
Marvin Döbel
JCJan Christoph
Jan Christoph
BACKGROUND Patient similarity is a fundamental concept in precision oncology, offering a pathway to personalized medicine by identifying patterns and shared characteristics among patients. This concept enables stratification into clinically meaningful subgroups, prediction of treatment responses, and the tailoring of therapeutic interventions to individual needs. Despite its transformative potential, the definition, measurement, and clinical application of patient similarity remain inconsistently established, creating challenges in its integration into cancer research and clinical practice. OBJECTIVE This study aimed to synthesize evidence on the multidimensional concept of patient similarity in cancer research by analyzing its application across different points of possible data types, methodological frameworks, biological contexts, and commonly studied cancer types. METHODS This scoping review followed the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews) framework and the Joanna Briggs Institute guidelines. A systematic search was conducted across PubMed, MEDLINE, LIVIVO, and Web of Science (covering the period from 1998 to February 2024) and was supplemented by snowball sampling and manual searches. Duplicate records were removed, and study selection was carried out in 3 phases: title and abstract screening, disagreement resolution, and full-text screening. Each step was independently performed by 2 reviewers in Rayyan, with conflicts resolved by a third reviewer. Data extraction was performed using a predefined template to capture methodological approaches, data types, cancer types, and research objectives related to similarity in patients with cancer. RESULTS This scoping review synthesized evidence from 137 studies, emphasizing the multidimensional concept of patient similarity in cancer research, which integrates diverse data types, methodological frameworks, research objectives, and cancer types. Transcriptomic data (92/137, 67.1%) and clinical data (65/137, 47.4%) were the most frequently used, often combined to enhance the comprehensiveness of similarity analyses. Machine learning (76/137, 55.5%) and network-based approaches (72/137, 52.5%) were prominent methods, reflecting their capacity to handle complex, high-dimensional data and uncover intricate relationships. Cancer subtype identification (70/137, 51.1%) and biomarker discovery (41/137, 29.9%) were the primary research objectives, underscoring the centrality of patient similarity in precision oncology. Breast, lung, and brain cancers were the most frequently studied, benefiting from established research frameworks and abundant datasets. Conversely, rare cancers were underrepresented, highlighting a critical gap in the generalizability of current methodologies. CONCLUSIONS This comprehensive scoping review examines the concept of patient similarity in cancer research and highlights the critical role of a multilayered perspective in capturing its complexity and identification to enhance understanding and application in precision oncology.

21 May 2026
Verified
Book Chapter
Open access
IMIryna Manuilova
Iryna Manuilova
AWAnnemarie B. Weise
Annemarie B. Weise
JFJulia Folwark
Julia Folwark
SHSonja Hiemer
Sonja Hiemer
SSSusann Schulze
Susann Schulze
JCJan Christoph
Jan Christoph
The PM4Onco project advances precision oncology by developing analytical and visual methods to support data-driven therapy decisions in Molecular Tumor Boards (MTBs). An interdisciplinary workshop at Martin Luther University Halle-Wittenberg in March 2025 explored strategies for defining and integrating patient similarity into MTB workflows. Using a synthetic oncology dataset, participants with clinical and data science backgrounds defined similarity criteria and structured search strategies for patient similarity. The workshop outcomes provide structured decision frameworks that operationalize patient similarity reasoning in a reproducible manner. Their implementation supports transparent and evidence-based analysis, fostering integration between algorithmic modeling and clinical expertise.

11 April 2024 in JMIR Preprints
Verified
Preprint
Open access
IMIryna Manuilova
Iryna Manuilova
JBJan Bossenz
Jan Bossenz
AWAnnemarie Bianka Weise
Annemarie Bianka Weise
DBDominik Boehm
Dominik Boehm
CSCosima Strantz
Cosima Strantz
JCJan Christoph
Jan Christoph
BACKGROUND Understanding the similarities of patients with cancer is essential to advancing personalized medicine, improving patient outcomes, and developing more effective and individualized treatments. It enables researchers to discover important patterns, biomarkers, and treatment strategies that can have a significant impact on cancer research and oncology. In addition, the identification of previously successfully treated patients supports oncologists in making treatment decisions for a new patient who is clinically or molecularly similar to the previous patient. OBJECTIVE The planned review aims to systematically summarize, map, and describe existing evidence to understand how patient similarity is defined and used in cancer research and clinical care. METHODS To systematically identify relevant studies and to ensure reproducibility and transparency of the review process, a comprehensive literature search will be conducted in several bibliographic databases, including Web of Science, PubMed, LIVIVIVO, and MEDLINE, covering the period from 1998 to February 2024. After the initial duplicate deletion phase, a study selection phase will be applied using Rayyan, which consists of 3 distinct steps: title and abstract screening, disagreement resolution, and full-text screening. To ensure the integrity and quality of the selection process, each of these steps is preceded by a pilot testing phase. This methodological process will culminate in the presentation of the final research results in a structured form according to the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) flowchart. The protocol has been registered in the Journal of Medical Internet Research. RESULTS This protocol outlines the methodologies used in conducting the scoping review. A search of the specified electronic databases and after removing duplicates resulted in 1183 unique records. As of March 2024, the review process has moved to the full-text evaluation phase. At this stage, data extraction will be conducted using a pretested chart template. CONCLUSIONS The scoping review protocol, centered on these main concepts, aims to systematically map the available evidence on patient similarity among patients with cancer. By defining the types of data sources, approaches, and methods used in the field, and aligning these with the research questions, the review will provide a foundation for future research and clinical application in personalized cancer care. This protocol will guide the literature search, data extraction, and synthesis of findings to achieve the review’s objectives. INTERNATIONAL REGISTERED REPORT DERR1-10.2196/58705